Based on the previous data demonstrating IL-13’s beneficial, anti-inflammatory actions in some models of neurological disorders [15–17], testing the immunomodulatory potential of exogenous IL-13 administration was highly justified in the context of ischemic stroke. Here, IL13 is linked to ischemic stroke.